MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Gwinnett
Anesthesia Service, P.C., a physician group practice based in
Lawrenceville, Georgia. The practice provides anesthesia services at
Gwinnett Medical Center in Lawrenceville and Duluth, as well as at
surgery centers and other outpatient facilities throughout those
metropolitan areas. The practice will become part of MEDNAX’s American
Anesthesiology division and is the third Georgia-based practice to join
the company.
Gwinnett Anesthesia was founded in 1983 and is a private group practice
consisting of 22 anesthesiologists, 59 anesthetists and 4 other clinical
and administrative support staff, providing anesthesia services across a
wide spectrum of subspecialty areas, including obstetric, cardiology,
gynecology, general surgery and orthopedic care, as well as acute and
chronic pain management services at its hospital and outpatient
facilities.
“As physicians, our focus is always on our patients, so partnering with
a national medical group with 30 years of business expertise, defined
office infrastructure, and a commitment to research, education, and
quality gives us the ability to maintain that focus,” said Larry
Goldstein, M.D. who will serve as medical director for the practice.
“Given the uncertainties in healthcare, we look forward to the stability
and growth that comes with being part of American Anesthesiology.”
MEDNAX’s American Anesthesiology division consists of more than 1,575
anesthesia providers, including more than 650 physicians and 925
anesthetists practicing in North Carolina, Florida, Georgia, Michigan,
New Jersey, Tennessee, Texas, and Virginia.
This practice was acquired for cash and the transaction is expected to
be immediately accretive to earnings. No additional terms of the
transaction were disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 330 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 1,575
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 2,150 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
